Michael C. Dugan
Impact in
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Cutaneous Melanoma Detection and Management
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 14
- Pancreatic and Hepatic Oncology Research 7
- Cancer-related Molecular Pathways 3
-
- Epigenetics and DNA Methylation 3
- Co-authors
- Vainutis K. Vaitkevicius (11 shared papers)Sanaa T. Dergham (8 shared papers)Fazlul H. Sarkar (8 shared papers)John D. Crissman (5 shared papers)Wei Du (4 shared papers)Michael Park (1 shared paper)Chris Taylor (1 shared paper)Mark Yim (1 shared paper)
- Journals
- Pancreas (6 papers)British Journal of Haematology (2 papers)Archives of Pathology & Laboratory Medicine (2 papers)Cancer (1 paper)Blood (1 paper)
- Partner nations
- United StatesAustraliaPoland
In The Last Decade
Michael C. Dugan
30 papers receiving 856 citations
Peers
Comparison fields: 5 of 82
- Oncology 494
- Cancer Research 130
- Biotechnology 57
- Molecular Biology 380
- Pathology and Forensic Medicine 77
Countries citing papers authored by Michael C. Dugan
This map shows the geographic impact of Michael C. Dugan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Dugan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Dugan more than expected).
Fields of papers citing papers by Michael C. Dugan
This network shows the impact of papers produced by Michael C. Dugan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Dugan. The network helps show where Michael C. Dugan may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael C. Dugan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 113 | |
| 2 | 2007 | 73 | |
| 3 | 1997 | 71 | |
| 4 | Frequent breakpoints in the 3p14.2 fragile site, FRA3B, in pancreatic tumors. | 1996 | 64 |
| 5 | 1997 | 64 | |
| 6 | 2011 | 56 | |
| 7 | 1997 | 53 | |
| 8 | 1997 | 52 | |
| 9 | 2003 | 43 | |
| 10 | 1998 | 39 | |
| 11 | Establishment of a human B-CLL xenograft model: utility as a preclinical therapeutic model. | 1996 | 35 |
| 12 | 1998 | 33 | |
| 13 | 1997 | 26 | |
| 14 | 2016 | 24 | |
| 15 | 2001 | 23 | |
| 16 | 1998 | 15 | |
| 17 | 1997 | 14 | |
| 18 | 1998 | 13 | |
| 19 | 1999 | 13 | |
| 20 | 2006 | 10 |
About Michael C. Dugan
Michael C. Dugan is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Pulmonary and Respiratory Medicine, having authored 30 papers that have together received 879 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (6 papers), Brain Metastases and Treatment (4 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer Research and Treatments (3 papers), Epigenetics and DNA Methylation (3 papers), AI in cancer detection (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Oncology (494 citations), Cancer Research (130 citations), Biotechnology (57 citations), Molecular Biology (380 citations) and Pathology and Forensic Medicine (77 citations). Michael C. Dugan has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Vainutis K. Vaitkevicius, Sanaa T. Dergham, Fazlul H. Sarkar, John D. Crissman, Wei Du, Michael Park, Chris Taylor, Mark Yim, Jimmy Sastra and Yong Q. Chen. Their work appears in journals such as Pancreas, British Journal of Haematology, Archives of Pathology & Laboratory Medicine, Cancer and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.